1290 related articles for article (PubMed ID: 26034365)
1. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
2. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in pediatric hepatitis C transplant recipients: analysis of the UNOS database.
Gupta M; Bahirwani R; Levine MH; Malik S; Goldberg D; Reddy KR; Shaked A
Pediatr Transplant; 2015 Mar; 19(2):153-63. PubMed ID: 25495572
[TBL] [Abstract][Full Text] [Related]
6. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
[TBL] [Abstract][Full Text] [Related]
7. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
8. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of adult liver re-transplant patients in the model for end-stage liver disease era: is it time to reconsider its indications?
Montenovo MI; Hansen RN; Dick AA
Clin Transplant; 2014 Oct; 28(10):1099-104. PubMed ID: 25041109
[TBL] [Abstract][Full Text] [Related]
10. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
11. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
Celik N; Kelly B; Soltys K; Squires JE; Vockley J; Shellmer DA; Strauss K; McKiernan P; Ganoza A; Sindhi R; Bond G; Mazariegos G; Khanna A
Clin Transplant; 2019 Nov; 33(11):e13721. PubMed ID: 31556146
[TBL] [Abstract][Full Text] [Related]
12. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
13. Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
Friedrich K; Smit M; Wannhoff A; Rupp C; Scholl SG; Antoni C; Dollinger M; Neumann-Haefelin C; Stremmel W; Weiss KH; Schemmer P; Gotthardt DN
J Gastroenterol Hepatol; 2016 Aug; 31(8):1470-5. PubMed ID: 26880589
[TBL] [Abstract][Full Text] [Related]
14. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
Dar FS; Bhatti AB; Dogar AW; Zia H; Amin S; Rana A; Nazer R; Khan NA; Khan EU; Rajput MZ; Salih M; Shah NH
Liver Transpl; 2015 Jul; 21(7):982-90. PubMed ID: 25891412
[TBL] [Abstract][Full Text] [Related]
15. Living donor liver transplantation with body-weight more or less than 10 kilograms.
Yang SC; Huang CJ; Chen CL; Wang CH; Wu SC; Shih TH; Juang SE; Lee YE; Jawan B; Cheng YF; Cheng KW
World J Gastroenterol; 2015 Jun; 21(23):7248-53. PubMed ID: 26109812
[TBL] [Abstract][Full Text] [Related]
16. Clinical analysis of liver transplantation in autoimmune liver diseases.
Zhong CP; Xi ZF; Xia Q
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
[TBL] [Abstract][Full Text] [Related]
17. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
18. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.
Umbro I; Tinti F; Mordenti M; Rossi M; Ianni S; Pugliese F; Ruberto F; Ginanni Corradini S; Nofroni I; Poli L; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1139-41. PubMed ID: 21620072
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.
Uguen T; Jezequel C; Ropert M; Houssel-Debry P; Latournerie M; Lainé F; Deugnier Y; Vigneau C; Boudjema K; Guyader D; Bardou-Jacquet E
Liver Int; 2016 Apr; 36(4):547-54. PubMed ID: 26502295
[TBL] [Abstract][Full Text] [Related]
20. Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.
Hu Z; Zhou J; Li Z; Xiang J; Zhang Q; Yan S; Wu J; Zhang M; Wang W; Zheng S
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):206-216. PubMed ID: 28107613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
